Frazier Healthcare Partners
Venture Capital
Active
Seattle, United States
219
32M
128
6.64
41
0.41
87
- Stages of investment
- Areas of investment
Summary
In 1991 was created Frazier Healthcare Partners, which is appeared as VC. The venture was found in North America in United States. The main department of described VC is located in the Seattle.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Frazier Healthcare Partners, startups are often financed by Versant Ventures, Sutter Hill Ventures, Alta Partners. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Three Arch Partners, Montreux Equity Partners. In the next rounds fund is usually obtained by Versant Ventures, Venrock, Advanced Technology Ventures.
The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Therapeutics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight AcertaPharma, Zeltiq Aesthetics, Tobira Therapeutics.
The typical startup value when the investment from Frazier Healthcare Partners is 10-50 millions dollars. This Frazier Healthcare Partners works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in 7-12 deals per year. The higher amount of exits for fund were in 2015. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
Besides them, we counted 17 critical employees of this fund in our database.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 1400000000
- Fund raised date
- 2021-05-27
Analytics
- Total investments
- 219
- Lead investments
- 41
- Exits
- 87
- Rounds per year
- 6.64
- Follow on index
- 0.41
- Investments by industry
- Biotechnology (163)
- Health Care (143)
- Therapeutics (79)
- Medical (75)
- Pharmaceutical (63) Show 30 more
- Investments by region
-
- United States (204)
- Netherlands (1)
- Ireland (3)
- Canada (2)
- China (1) Show 1 more
- Peak activity year
- 2007
- Number of Unicorns
- 4
- Number of Decacorns
- 5
- Number of Minotaurs
- 4
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 193M
- Group Appearance index
- 0.87
- Avg. company exit year
- 9
- Avg. multiplicator
- 3.54
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Sojournix | 04 Jan 2019 | Biotechnology, Health Care, Medical | Late Stage Venture | 44M | United States, Massachusetts |
Zelos Therapeutics | 19 May 2005 | Health Care, Medical, Pharmaceutical, Therapeutics | Early Stage Venture | 42M | United States, Pennsylvania, Conshohocken |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.